Home › NDC Lookup › RxCUI directory › RxCUI 2166196

5 ML levothyroxine sodium 0.04 MG/ML Injection — RxCUI 2166196

RxNorm drug concept · Semantic clinical drug
RxCUI 2166196 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2166196
Official name5 ML levothyroxine sodium 0.04 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslevothyroxine sodium 200 MCG per 5 ML Injection; levothyroxine sodium 200 MCG in 5 mL Injection; levothyroxine sodium 40 MCG/ML in 5 ML Injection
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)497 prescriptions · 11 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Levothyroxine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It replaces thyroid hormone when your thyroid doesn’t make enough, a condition called hypothyroidism. Oral forms are also used with surgery and radioiodine for certain thyroid canc...
  • Oral forms are usually taken once a day on an empty stomach, about 15 to 60 minutes before breakfast, depending on the product. Keep calcium, iron and antacids at least 4 hours awa...
  • Full effect may take 4 to 6 weeks. Your doctor will check TSH and/or T4 blood tests to adjust your dose.
  • No. It doesn’t cause weight loss at normal doses if your thyroid is normal. Larger doses can be seriously toxic.
📖 Read our full Levothyroxine guide →

🕸️ Concept Web — How 5 ML levothyroxine sodium 0.04 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 5 ML levothyroxine sodium 0.04 MG/ML Injection RxCUI 2166196

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Levothyroxine 10582
    • Levothyroxine sodium 40144
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Levothyroxine Injection 1868004
    • Levothyroxine sodium Injection 2647504
    • Levothyroxine Injectable Product 1602750
    • Levothyroxine sodium Injectable Product 2662329
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Levothyroxine sodium 0.04 MG/ML 2166195

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Levothyroxine sodium 0.04 MG/ML SCDC · 2166195
  • Levothyroxine Injection SCDF · 1868004
  • Levothyroxine sodium Injection SCDFP · 2647504
  • Levothyroxine Injectable Product SCDG · 1602750
  • Levothyroxine sodium Injectable Product SCDGP · 2662329

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 2166196 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
63323-0885-10 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-885-10) / 5 mL in 1... Levothyroxine Sodium Fresenius Kabi USA, LLC 2018-05-29
63323-0890-10 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-890-10) / 5 mL in 1... Levothyroxine Sodium Fresenius Kabi USA, LLC 2018-05-29
63323-0895-10 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-895-10) / 5 mL in 1... Levothyroxine Sodium Fresenius Kabi USA, LLC 2018-05-29
Observed labelers: Fresenius Kabi USA, LLC (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J0651 Inj, levothyroxine, freskabi 3 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.